Transferrin is a drug candidate for the treatment of dry age-related macular degeneration (AMD).
Youale J, Bigot K, Jaworski T, Lebon C, Françon A, Delaunay K, Bénard R, De Bastard T, Daruich A, Kaddour N, Bordet T, Behar-Cohen F, Picard E.
Youale J, et al. Among authors: lebon c.
Cell Death Dis. 2025 Oct 6;16(1):692. doi: 10.1038/s41419-025-07950-0.
Cell Death Dis. 2025.
PMID: 41053100
Free PMC article.